{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:26:16Z","timestamp":1778171176783,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR002377"],"award-info":[{"award-number":["UL1 TR002377"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1136\/ijgc-2020-002158","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T13:35:49Z","timestamp":1616765749000},"page":"702-708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer"],"prefix":"10.1016","volume":"31","author":[{"given":"Deepa Maheswari","family":"Narasimhulu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S","family":"Block","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy L","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michaela","family":"McGree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanika","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carrie","family":"Langstraat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivy","family":"Petersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9413-316X","authenticated-orcid":false,"given":"Gretchen","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-002158_bb0010","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S1470-2045(19)30395-X","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial","volume":"20","author":"de Boer","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ygyno.2019.05.002","article-title":"Adjuvant combined-modality therapy for stage IIIC endometrioid and non-endometrioid endometrial cancer","volume":"154","author":"Chapman","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0020","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-002158_bb0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ygyno.2019.07.021","article-title":"Sequencing of therapy in women with stage III endometrial carcinoma receiving adjuvant combination chemotherapy and radiation","volume":"155","author":"Latham","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0035","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2015.01.546","article-title":"Sequential versus \"sandwich\" sequencing of adjuvant chemoradiation for the treatment of stage III uterine endometrioid adenocarcinoma","volume":"137","author":"Lu","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ygyno.2008.01.023","article-title":"Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging","volume":"109","author":"Mariani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0045","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.ejca.2010.06.002","article-title":"Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer--results from two randomised studies","volume":"46","author":"Hogberg","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2020-002158_bb0050","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00280-013-2276-9","article-title":"Adjuvant sequential chemoradiation therapy in high-risk endometrial cancer: results of a prospective, multicenter phase-II study of the NOGGO (North-eastern German Society of Gynaecological Oncology)","volume":"72","author":"Mustea","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1136\/ijgc-2020-002158_bb0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ygyno.2006.02.007","article-title":"Final analysis of RTOG 9708: adjuvant postoperative irradiation combined with cisplatin\/paclitaxel chemotherapy following surgery for patients with high-risk endometrial cancer","volume":"103","author":"Greven","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0060","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ygyno.2013.01.025","article-title":"A prospective phase II study of chemoradiation followed by adjuvant chemotherapy for FIGO stage I-IIIA (1988) uterine papillary serous carcinoma of the endometrium","volume":"129","author":"Jhingran","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0065","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/cncr.29337","article-title":"NRG Oncology\/RTOG 0921: a phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer","volume":"121","author":"Viswanathan","year":"2015","journal-title":"Cancer"},{"key":"10.1136\/ijgc-2020-002158_bb0070","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2015.11.021","article-title":"Adjuvant concurrent chemoradiation followed by chemotherapy for high-risk endometrial cancer","volume":"140","author":"Ren","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0075","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ygyno.2010.12.338","article-title":"A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a \u201cSandwich\u201d method for stage III, IV, and recurrent endometrial cancer","volume":"121","author":"Geller","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0080","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.ygyno.2012.02.003","article-title":"A phase II evaluation of docetaxel and carboplatin followed by tumor volume directed pelvic plus or minus paraaortic irradiation for stage III endometrial cancer","volume":"125","author":"Scribner","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0085","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.ygyno.2018.03.004","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone in high-risk endometrial cancer: a systematic review and meta-analysis","volume":"149","author":"Yi","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0090","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2008.03.020","article-title":"Surgically staged high-risk endometrial cancer: randomized study of adjuvant radiotherapy alone vs. sequential chemo-radiotherapy","volume":"110","author":"Kuoppala","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0095","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1200\/JCO.18.01575","article-title":"Phase III trial: adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage endometrial cancer","volume":"37","author":"Randall","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0090-8258(90)90166-I","article-title":"Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group study","volume":"36","author":"Morrow","year":"1990","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0105","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijrobp.2016.06.2448","article-title":"Timing of radiation therapy and chemotherapy after breast-conserving surgery for node-positive breast cancer: long-term results from International Breast Cancer Study Group trials VI and VII","volume":"96","author":"Karlsson","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2020-002158_bb0110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/IGC.0000000000001162","article-title":"What is the optimal adjuvant treatment sequence for node-positive endometrial cancer? Results of a National Cancer Database analysis","volume":"28","author":"Modh","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"10.1136\/ijgc-2020-002158_bb0115","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ygyno.2009.06.005","article-title":"A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer","volume":"114","author":"Secord","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0120","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2019.30.e28","article-title":"A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma","volume":"30","author":"Onal","year":"2019","journal-title":"J Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-002158_bb0125","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ygyno.2019.09.011","article-title":"Role of lymphadenectomy in endometrial cancer with nonbulky lymph node metastasis: comparison of comprehensive surgical staging and sentinel lymph node algorithm","volume":"155","author":"Multinu","year":"2019","journal-title":"Gynecol Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24023351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-002158","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:38:40Z","timestamp":1753223920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24023351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1048891X24023351"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-002158","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sequencing chemotherapy before radiotherapy for women with stage IIIC endometrial cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-002158","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}